Cargando…
Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances
Hepatobiliary tumors, which include cholangiocarcinoma, hepatocellular carcinoma (HCC), and gallbladder cancer, are common cancers that have high morbidity and mortality rates and poor survival outcomes. In humans, the microbiota is comprised of symbiotic microbial cells (10-100 trillion) that belon...
Autores principales: | Qin, Hao, Yuan, Baowen, Huang, Wei, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339707/ https://www.ncbi.nlm.nih.gov/pubmed/35924173 http://dx.doi.org/10.3389/fonc.2022.924696 |
Ejemplares similares
-
A Review of Circulating Tumor DNA in Hepatobiliary Malignancies
por: Mody, Kabir, et al.
Publicado: (2018) -
Recent advances in vascularized tumor-on-a-chip
por: Huang, Christina Bao Xian, et al.
Publicado: (2023) -
m(6)A regulators featured by tumor immune microenvironment landscapes and correlated with immunotherapy in non-small cell lung cancer (NSCLC)
por: Yuan, Baowen, et al.
Publicado: (2022) -
Mucin utilization by gut microbiota: recent advances on characterization of key enzymes
por: Raba, Grete, et al.
Publicado: (2023) -
Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
por: Li, Jing, et al.
Publicado: (2022)